Polycystic Ovary Syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: For 30 patients with Polycystic Ovarian Syndrome, selected by a specialist based on the Rotterdam index, a written consent is given after explaining the topic of th
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: PCOS diagnosis by a Specialist (Base on Rotterdam benchmark) Women aged 18 to 40 Years Old (It is preferable not to be at the Age of Development or Menopause). Body mass index larger equal to 25, smaller and equal to 35. stability in the type and dose of medication in the last 6 months. Lack of acute heart disease, Increased Prolactin levels, Liver, Kidney, Digestive, Thyroid and Diabetes, Androgens secreting Tumors. Use of antioxidant supplements and drugs that affect inflammatory and oxidative stress factors. Drug in the last 6 months
Exclusion criteria
Exclusion criteria: Unwilling to participate in the study Pregnancy Misdiagnosis of demographic or anthropometric information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malondialdehyde. Timepoint: The beginning and the end of the study. Method of measurement: Biochemistry.;Total Antioxidant Capacity. Timepoint: The beginning and the end of the study. Method of measurement: Biochemistry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean changes in the level of the C reactive protein. Timepoint: The beginning and the end of the study. Method of measurement: Biochemistry.;Depression anxiety stress score. Timepoint: The beginning and the end of the study. Method of measurement: Stress Anxiety Depression Questionnaire 7 question. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Sohaei
Esfahan University of Medical Sciences
Outcome results
None listed